TMPRSS6 and IRIDA syndrome: Moreover, our previous small study indicated that the TSAT/hepcidin ratio was able to discriminate between biallelic and monoallelic IRIDA patients and between monoallelic IRIDA patients and their phenotypically unaffected relatives with the same heterozygous TMPRSS6 variant, even after parenteral iron therapy had been given [11].